Public Policy

Is Pakistan the Next Big Cannabis Exporter?
Public Policy Is Pakistan the Next Big Cannabis Exporter?

In a strategic pivot that could reshape its economic landscape, Pakistan has formally stepped onto the global stage, not for its traditional exports, but for a crop with a complex past and a lucrative future: cannabis. The nation's decision to establish a state-controlled industry for

Are Punitive Damages Fueling A Doctor Shortage?
Public Policy Are Punitive Damages Fueling A Doctor Shortage?

The silent exodus of medical professionals from a state can often be traced not to a single event but to the slow, steady erosion of a sustainable practice environment. In the intricate ecosystem of American healthcare, a complex interplay of legal precedent, economic pressure, and patient advocacy

Ontario's Private Health Plan Raises Two-Tier Fears
Public Policy Ontario's Private Health Plan Raises Two-Tier Fears

Ontario's healthcare landscape is undergoing a seismic transformation, shifting publicly insured procedures into privately owned clinics in a bid to modernize access and cut down wait times. This strategic pivot, however, has ignited a fierce debate, placing the promise of efficiency in direct

FDA Fast Tracks New Drug to Combat Fungal Superbugs
Public Policy FDA Fast Tracks New Drug to Combat Fungal Superbugs

While the world's attention has been focused on viral threats, a far more insidious and resilient danger has been quietly spreading through hospitals and communities, threatening to render our medical advancements useless. The rise of drug-resistant fungal infections represents a formidable

Congress Unveils Landmark PBM Reform in Spending Bill
Public Policy Congress Unveils Landmark PBM Reform in Spending Bill

Navigating the Complex Landscape of Pharmacy Benefit Management After years of operating in the shadows of the American healthcare system, the powerful middlemen controlling prescription drug access are finally being brought into the light by a sweeping act of Congress. These entities, known as

Could New FDA Rules Speed Up Myeloma Therapies?
Public Policy Could New FDA Rules Speed Up Myeloma Therapies?

The remarkable progress in treating multiple myeloma has created a formidable, and somewhat ironic, challenge for the very innovation needed to build upon that success. As current therapies drive patients into longer and deeper remissions, the traditional benchmarks for proving a new drug’s worth h

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later